The sphingosine-1-phosphate receptor agonist etrasimod in ulcerative colitis

Lancet. 2023 Apr 8;401(10383):1132-1133. doi: 10.1016/S0140-6736(23)00228-3. Epub 2023 Mar 2.

Authors

Raja Atreya¹, Markus F Neurath²

Affiliations

¹ First Department of Medicine, Erlangen University Hospital, Friedrich-Alexander-University Erlangen-Nürnberg, 91054 Erlangen, Germany; Deutsches Zentrum Immuntherapie, Erlangen, Germany. Electronic address: raja.atreya@uk-erlangen.de.
² First Department of Medicine, Erlangen University Hospital, Friedrich-Alexander-University Erlangen-Nürnberg, 91054 Erlangen, Germany; Deutsches Zentrum Immuntherapie, Erlangen, Germany.

PMID: 36871570
DOI: 10.1016/S0140-6736(23)00228-3

No abstract available

Publication types

Comment

MeSH terms

Acetates
Colitis*
Colitis, Ulcerative* / drug therapy
Humans
Sphingosine-1-Phosphate Receptors

Substances

etrasimod
Sphingosine-1-Phosphate Receptors
Acetates